Home

Parkinson's Disease

Parkinson's Disease

Read time: 5 min

Ethics in movement disorders – what the clinician needs to know

Ethics seeks to resolve questions of human morality by defining concepts such as good and evil,...

Parkinson's Disease

Read time: 3 min

DaT scan in daily practice – making PD differential diagnosis easier

Correctly diagnosing Parkinson’s disease (PD) can be challenging, especially when based...

Parkinson's Disease

Read time: 4 min

Alpha-synuclein and tau - fatal attraction or neighbors’ squabble?

An intriguingly titled symposium queried whether there was a fatal attraction between tau and alpha...

Read time: 3 min

Congress highlights

Transforming healthcare — the changing landscape of patient engagement

Patient engagement is the facilitation and strengthening of the role of patients as co-producers of...

Read time: 3 min

Congress highlights

Early dialogues with patients are informing medicines development

A 200-strong audience of health economics and outcomes research professionals at ISPOR 2018...

Parkinson's Disease

Read time: 3 min

New therapeutic technologies and targets for Parkinson’s disease

A gastroretentive capsule containing multiple layers of biodegradable film, intraoral infusion via...

Parkinson's Disease

Slide library - The Lundbeck Institute Campus

Neurobiology and aetiology - New Slides for Parkinson’s disease now available

Parkinson's Disease

Read time: 5 min

Congress highlights

Gait freezing - defrosted

The assessment and therapeutic options for complex gait disorders has never been so promising....

Parkinson's Disease

Read time: 3 min

Congress highlights

Getting rid of alpha-synuclein – active and passive immunotherapy, or maybe targeting LRRK2?

Immunotherapy is an established treatment option for many forms of cancer, and recently received...

Parkinson's Disease

Read time: 3 min

Congress highlights

Managing strategies for Parkinson’s disease: A multipronged approach for a multifaceted illness

Parkinson’s disease is characterized by motor symptoms and a wide range of non-motor symptoms...

Parkinson's Disease

Read time: 4 min

Congress highlights

Non-motor symptoms – influencing ‘ON’ and ‘OFF’ in Parkinson’s disease

A broad spectrum of non-motor symptoms is highly prevalent in Parkinson’s disease (PD) which...

Alzheimer's Disease, Parkinson's Disease

Read time: 3 min

Deep brain stimulation, transcranial magnetic stimulation and rhythmic auditory cues can improve motor symptoms, speech and gait

Nonpharmacological approaches for the treatment of neurodegenerative diseases were discussed at a...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country